Abiraterone
The metabolism of Rabeprazole can be decreased when combined with Abiraterone.
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Rabeprazole.
Acetyl salicylate
The metabolism of Acetylsalicylic acid can be decreased when combined with Rabeprazole.
Advertisement
Acetyl Sulfisoxazole
The metabolism of Rabeprazole can be decreased when combined with Acetyl sulfisoxazole.
Alendronate
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Rabeprazole.
Alendronic acid
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Rabeprazole.
Advertisement
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Rabeprazole.
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Rabeprazole.
Amiodarone
The metabolism of Rabeprazole can be decreased when combined with Amiodarone.
Advertisement
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Rabeprazole.
Amodiaquine
The serum concentration of Amodiaquine can be increased when it is combined with Rabeprazole.
Amphetamine
Rabeprazole can cause an increase in the absorption of Amphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Amprenavir
The metabolism of Amprenavir can be decreased when combined with Rabeprazole.
Anhydrous Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Rabeprazole.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Rabeprazole.
Apalutamide
The serum concentration of Rabeprazole can be decreased when it is combined with Apalutamide.
Apixaban
The metabolism of Apixaban can be decreased when combined with Rabeprazole.
Aprepitant
The serum concentration of Rabeprazole can be increased when it is combined with Aprepitant.
Armodafinil
The metabolism of Rabeprazole can be decreased when combined with Armodafinil.
Aspirin
The metabolism of Acetylsalicylic acid can be decreased when combined with Rabeprazole.
Asunaprevir
The serum concentration of Asunaprevir can be increased when it is combined with Rabeprazole.
Atazanavir
Rabeprazole can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Atomoxetine
The metabolism of Rabeprazole can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Rabeprazole is combined with Atorvastatin.
Azelastine
The metabolism of Azelastine can be decreased when combined with Rabeprazole.
Benzyl Alcohol
The metabolism of Benzyl alcohol can be decreased when combined with Rabeprazole.
Bioallethrin
The metabolism of Bioallethrin can be decreased when combined with Rabeprazole.
Boceprevir
The metabolism of Rabeprazole can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Rabeprazole can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Rabeprazole can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Rabeprazole can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Rabeprazole.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Rabeprazole.
Brigatinib
The metabolism of Brigatinib can be decreased when combined with Rabeprazole.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Rabeprazole.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Rabeprazole.
Buprenorphine
The metabolism of Buprenorphine can be decreased when combined with Rabeprazole.
Bupropion
The metabolism of Bupropion can be decreased when combined with Rabeprazole.
Cabazitaxel
The metabolism of Cabazitaxel can be decreased when combined with Rabeprazole.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Rabeprazole.
Caffeine
The metabolism of Caffeine can be decreased when combined with Rabeprazole.
Carbamazepine
The metabolism of Rabeprazole can be increased when combined with Carbamazepine.
Carbinoxamine
The metabolism of Carbinoxamine can be decreased when combined with Rabeprazole.
Cefditoren
The serum concentration of Cefditoren can be decreased when it is combined with Rabeprazole.
Ceritinib
The serum concentration of Rabeprazole can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Rabeprazole.
Chloramphenicol
The metabolism of Rabeprazole can be decreased when combined with Chloramphenicol.
Chloroquine
The metabolism of Chloroquine can be decreased when combined with Rabeprazole.
Cholecalciferol
The metabolism of Rabeprazole can be decreased when combined with Cholecalciferol.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Rabeprazole.
Cimetidine
The metabolism of Rabeprazole can be decreased when combined with Cimetidine.
Cisapride
The metabolism of Cisapride can be decreased when combined with Rabeprazole.
Citalopram
The metabolism of Rabeprazole can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Rabeprazole can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Rabeprazole can be decreased when combined with Clemastine.
Clodronic Acid
The therapeutic efficacy of Clodronic Acid can be decreased when used in combination with Rabeprazole.
Clopidogrel
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Rabeprazole resulting in a loss in efficacy.
Clotrimazole
The metabolism of Rabeprazole can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Clozapine can be decreased when combined with Rabeprazole.
Cobicistat
The metabolism of Rabeprazole can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Rabeprazole.
Crizotinib
The metabolism of Rabeprazole can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Rabeprazole can be decreased when combined with Curcumin.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Rabeprazole.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Rabeprazole.
Cyclosporine
The metabolism of Rabeprazole can be decreased when combined with Cyclosporine.
Cysteamine
The therapeutic efficacy of Cysteamine can be decreased when used in combination with Rabeprazole.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be reduced when Dabigatran etexilate is used in combination with Rabeprazole resulting in a loss in efficacy.
Dabrafenib
The serum concentration of Dabrafenib can be decreased when it is combined with Rabeprazole.
Dapsone
The metabolism of Dapsone can be decreased when combined with Rabeprazole.
Darunavir
The metabolism of Rabeprazole can be decreased when combined with Darunavir.
Dasabuvir
The metabolism of Dasabuvir can be decreased when combined with Rabeprazole.
Dasatinib
The serum concentration of Dasatinib can be decreased when it is combined with Rabeprazole.
Dasatinib Anhydrous
The serum concentration of Dasatinib can be decreased when it is combined with Rabeprazole.
Deferasirox
The serum concentration of Rabeprazole can be decreased when it is combined with Deferasirox.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Rabeprazole.
Dexmethylphenidate
Rabeprazole can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextroamphetamine
Rabeprazole can cause an increase in the absorption of Dextroamphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Rabeprazole.
Diazepam
The metabolism of Diazepam can be decreased when combined with Rabeprazole.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Rabeprazole.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Rabeprazole.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Rabeprazole.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Rabeprazole.
Diltiazem
The metabolism of Rabeprazole can be decreased when combined with Diltiazem.
Domperidone
The metabolism of Domperidone can be decreased when combined with Rabeprazole.
Doxycycline
The metabolism of Rabeprazole can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Rabeprazole can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Rabeprazole can be decreased when combined with Dronedarone.
Efavirenz
The metabolism of Rabeprazole can be decreased when combined with Efavirenz.
Eltrombopag
The metabolism of Eltrombopag can be decreased when combined with Rabeprazole.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Rabeprazole.
Enzalutamide
The serum concentration of Rabeprazole can be decreased when it is combined with Enzalutamide.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Rabeprazole.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Rabeprazole.
Erlotinib
The serum concentration of Erlotinib can be decreased when it is combined with Rabeprazole.
Erythromycin
The metabolism of Rabeprazole can be decreased when combined with Erythromycin.
Eslicarbazepine Acetate
The metabolism of Rabeprazole can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Rabeprazole can be decreased when combined with Esomeprazole.
Estradiol
The metabolism of Estradiol can be decreased when combined with Rabeprazole.
Estradiol 3-Benzoate
The metabolism of Estradiol benzoate can be decreased when combined with Rabeprazole.
Estradiol acetate
The metabolism of Estradiol acetate can be decreased when combined with Rabeprazole.
Estradiol Cypionate
The metabolism of Estradiol cypionate can be decreased when combined with Rabeprazole.
Estradiol Valerate
The metabolism of Estradiol valerate can be decreased when combined with Rabeprazole.
Eszopiclone
The metabolism of Eszopiclone can be decreased when combined with Rabeprazole.
Etidronate
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Rabeprazole.
Etidronic Acid
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Rabeprazole.
Etravirine
The metabolism of Rabeprazole can be decreased when combined with Etravirine.
Ferric Carboxymaltose
Rabeprazole can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Rabeprazole can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Rabeprazole.
Fluconazole
The serum concentration of Rabeprazole can be increased when it is combined with Fluconazole.
Fluorouracil
The metabolism of Fluorouracil can be decreased when combined with Rabeprazole.
Fluoxetine
The metabolism of Rabeprazole can be decreased when combined with Fluoxetine.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Rabeprazole.
Fluvoxamine
The metabolism of Rabeprazole can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Rabeprazole can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Rabeprazole can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Rabeprazole can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Rabeprazole can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Rabeprazole can be increased when it is combined with Fusidic Acid.
Gefitinib
The serum concentration of Gefitinib can be decreased when it is combined with Rabeprazole.
Gemfibrozil
The metabolism of Rabeprazole can be decreased when combined with Gemfibrozil.
Halofantrine
The metabolism of Halofantrine can be decreased when combined with Rabeprazole.
Hypoxis hemerocallidea root extract
The serum concentration of Rabeprazole can be decreased when it is combined with St. John's Wort.
Ibandronate
The therapeutic efficacy of Ibandronate can be decreased when used in combination with Rabeprazole.
Ibandronic Acid
The therapeutic efficacy of Ibandronate can be decreased when used in combination with Rabeprazole.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Rabeprazole.
Ibuprofen
The metabolism of Ibuprofen can be decreased when combined with Rabeprazole.
Idelalisib
The metabolism of Rabeprazole can be decreased when combined with Idelalisib.
Ifosfamide
The metabolism of Ifosfamide can be decreased when combined with Rabeprazole.
Imatinib
The metabolism of Rabeprazole can be decreased when combined with Imatinib.
Indinavir
The serum concentration of Indinavir can be decreased when it is combined with Rabeprazole.
INDINAVIR ANHYDROUS
The serum concentration of Indinavir can be decreased when it is combined with Rabeprazole.
Irbesartan
The metabolism of Irbesartan can be decreased when combined with Rabeprazole.
Iron
Rabeprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Rabeprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
Rabeprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
Rabeprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isavuconazole
The serum concentration of Rabeprazole can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Rabeprazole can be decreased when combined with Isavuconazonium.
Isoniazid
The metabolism of Rabeprazole can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Rabeprazole can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.
Ivacaftor
The serum concentration of Rabeprazole can be increased when it is combined with Ivacaftor.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Rabeprazole.
Ketamine
The metabolism of Ketamine can be decreased when combined with Rabeprazole.
Ketoconazole
The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.
Lansoprazole
The metabolism of Lansoprazole can be decreased when combined with Rabeprazole.
Lapatinib
The metabolism of Lapatinib can be decreased when combined with Rabeprazole.
Ledipasvir
The serum concentration of Ledipasvir can be decreased when it is combined with Rabeprazole.
Levomilnacipran
The metabolism of Levomilnacipran can be decreased when combined with Rabeprazole.
Lidocaine
The metabolism of Lidocaine can be decreased when combined with Rabeprazole.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Rabeprazole.
Loperamide
The metabolism of Loperamide can be decreased when combined with Rabeprazole.
Lopinavir
The metabolism of Rabeprazole can be decreased when combined with Lopinavir.
Loratadine
The metabolism of Loratadine can be decreased when combined with Rabeprazole.
Losartan
The metabolism of Losartan can be decreased when combined with Rabeprazole.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Rabeprazole.
Luliconazole
The serum concentration of Rabeprazole can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Rabeprazole can be decreased when it is combined with Lumacaftor.
Medronate
The therapeutic efficacy of Technetium Tc-99m medronate can be decreased when used in combination with Rabeprazole.
Mefenamic Acid
The metabolism of Mefenamic acid can be decreased when combined with Rabeprazole.
Meloxicam
The metabolism of Meloxicam can be decreased when combined with Rabeprazole.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Rabeprazole.
Mesalamine
The therapeutic efficacy of Mesalazine can be decreased when used in combination with Rabeprazole.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Rabeprazole.
Methadone
The metabolism of Methadone can be decreased when combined with Rabeprazole.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Rabeprazole.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Rabeprazole.
Methylphenidate
Rabeprazole can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Rabeprazole.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Rabeprazole.
Mifepristone
The serum concentration of Rabeprazole can be increased when it is combined with Mifepristone.
Mirtazapine
The metabolism of Mirtazapine can be decreased when combined with Rabeprazole.
Mitotane
The serum concentration of Rabeprazole can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Rabeprazole can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Rabeprazole can be decreased when combined with Modafinil.
Morphine
The metabolism of Morphine can be decreased when combined with Rabeprazole.
MYCOPHENOLATE
The serum concentration of Mycophenolic acid can be decreased when it is combined with Rabeprazole.
Mycophenolate Mofetil
The metabolism of Mycophenolate mofetil can be decreased when combined with Rabeprazole.
Mycophenolic Acid
The serum concentration of Mycophenolic acid can be decreased when it is combined with Rabeprazole.
Naloxone
The metabolism of Naloxone can be decreased when combined with Rabeprazole.
Naproxen
The metabolism of Naproxen can be decreased when combined with Rabeprazole.
Nefazodone
The metabolism of Rabeprazole can be decreased when combined with Nefazodone.
Nelfinavir
The serum concentration of the active metabolites of Nelfinavir can be reduced when Nelfinavir is used in combination with Rabeprazole resulting in a loss in efficacy.
Netupitant
The serum concentration of Rabeprazole can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Rabeprazole can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Rabeprazole can be decreased when combined with Nicardipine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Rabeprazole.
Nicotine
The metabolism of Nicotine can be decreased when combined with Rabeprazole.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Rabeprazole.
Nilotinib
The serum concentration of Nilotinib can be decreased when it is combined with Rabeprazole.
Olaparib
The metabolism of Rabeprazole can be decreased when combined with Olaparib.
Olodaterol
The metabolism of Olodaterol can be decreased when combined with Rabeprazole.
Ombitasvir
The metabolism of Ombitasvir can be decreased when combined with Rabeprazole.
Omeprazole
The metabolism of Rabeprazole can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Rabeprazole can be increased when it is combined with Osimertinib.
Paclitaxel
The metabolism of Paclitaxel can be decreased when combined with Rabeprazole.
Palbociclib
The serum concentration of Rabeprazole can be increased when it is combined with Palbociclib.
Pamidronate
The therapeutic efficacy of Pamidronate can be decreased when used in combination with Rabeprazole.
Pamidronic Acid
The therapeutic efficacy of Pamidronate can be decreased when used in combination with Rabeprazole.
Pantoprazole
The metabolism of Rabeprazole can be decreased when combined with Pantoprazole.
Paramethadione
The metabolism of Paramethadione can be decreased when combined with Rabeprazole.
Paregoric
The metabolism of Morphine can be decreased when combined with Rabeprazole.
Pazopanib
The serum concentration of Pazopanib can be decreased when it is combined with Rabeprazole.
Pentamidine
The metabolism of Pentamidine can be decreased when combined with Rabeprazole.
Pentobarbital
The metabolism of Rabeprazole can be increased when combined with Pentobarbital.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Rabeprazole.
Perphenazine
The metabolism of Perphenazine can be decreased when combined with Rabeprazole.
Phenobarbital
The metabolism of Rabeprazole can be increased when combined with Phenobarbital.
Phenprocoumon
The metabolism of Phenprocoumon can be decreased when combined with Rabeprazole.
Phenytoin
The metabolism of Rabeprazole can be increased when combined with Phenytoin.
Pioglitazone
The metabolism of Pioglitazone can be decreased when combined with Rabeprazole.
Piroxicam
The metabolism of Piroxicam can be decreased when combined with Rabeprazole.
Piroxicam-Beta-Cyclodextrin
The metabolism of Piroxicam can be decreased when combined with Rabeprazole.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Rabeprazole.
Ponatinib
The metabolism of Ponatinib can be decreased when combined with Rabeprazole.
Posaconazole
The serum concentration of Posaconazole can be decreased when it is combined with Rabeprazole.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Rabeprazole.
Primidone
The metabolism of Rabeprazole can be increased when combined with Primidone.
Progesterone
The metabolism of Progesterone can be decreased when combined with Rabeprazole.
Propofol
The metabolism of Propofol can be decreased when combined with Rabeprazole.
Quinidine
The metabolism of Quinidine can be decreased when combined with Rabeprazole.
Quinine
The metabolism of Quinine can be decreased when combined with Rabeprazole.
Raltegravir
The serum concentration of Raltegravir can be increased when it is combined with Rabeprazole.
Ranolazine
The metabolism of Rabeprazole can be decreased when combined with Ranolazine.
Repaglinide
The metabolism of Repaglinide can be decreased when combined with Rabeprazole.
Rifabutin
The metabolism of Rabeprazole can be increased when combined with Rifabutin.
Rifampin
The metabolism of Rabeprazole can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Rabeprazole can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Rabeprazole.
Riociguat
The serum concentration of Riociguat can be decreased when it is combined with Rabeprazole.
Risedronate
The serum concentration of Risedronate can be increased when it is combined with Rabeprazole.
Risedronic Acid
The serum concentration of Risedronate can be increased when it is combined with Rabeprazole.
Rofecoxib
The metabolism of Rofecoxib can be decreased when combined with Rabeprazole.
Rosiglitazone
The metabolism of Rosiglitazone can be decreased when combined with Rabeprazole.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Rabeprazole.
Rucaparib
The metabolism of Rabeprazole can be decreased when combined with Rucaparib.
Saquinavir
The serum concentration of Saquinavir can be increased when it is combined with Rabeprazole.
Saquinavir Mesylate
The serum concentration of Saquinavir can be increased when it is combined with Rabeprazole.
Sarilumab
The therapeutic efficacy of Rabeprazole can be decreased when used in combination with Sarilumab.
Selegiline
The metabolism of Selegiline can be decreased when combined with Rabeprazole.
Selexipag
The metabolism of Selexipag can be decreased when combined with Rabeprazole.
Sertraline
The metabolism of Rabeprazole can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Rabeprazole can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Rabeprazole can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Rabeprazole can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Rabeprazole.
Sitagliptin
The metabolism of Sitagliptin can be decreased when combined with Rabeprazole.
Sitagliptin Phosphate
The metabolism of Sitagliptin can be decreased when combined with Rabeprazole.
Sorafenib
The metabolism of Sorafenib can be decreased when combined with Rabeprazole.
ST. JOHN'S WORT EXTRACT
The serum concentration of Rabeprazole can be decreased when it is combined with St. John's Wort.
Sucroferric Oxyhydroxide
Rabeprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sulfadiazine
The metabolism of Sulfadiazine can be decreased when combined with Rabeprazole.
Sulfinpyrazone
The metabolism of Sulfinpyrazone can be decreased when combined with Rabeprazole.
Sulfisoxazole
The metabolism of Rabeprazole can be decreased when combined with Sulfisoxazole.
Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Rabeprazole.
Tazarotene
The metabolism of Tazarotene can be decreased when combined with Rabeprazole.
Technetium Tc 99m Medronate
The therapeutic efficacy of Technetium Tc-99m medronate can be decreased when used in combination with Rabeprazole.
Telaprevir
The metabolism of Rabeprazole can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Rabeprazole can be decreased when combined with Telithromycin.
Temazepam
The metabolism of Temazepam can be decreased when combined with Rabeprazole.
Terbinafine
The metabolism of Terbinafine can be decreased when combined with Rabeprazole.
Testosterone
The metabolism of Testosterone can be decreased when combined with Rabeprazole.
Testosterone Cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Rabeprazole.
Testosterone Enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Rabeprazole.
Testosterone Undecanoate
The metabolism of Testosterone undecanoate can be decreased when combined with Rabeprazole.
Theophylline
The metabolism of Theophylline can be decreased when combined with Rabeprazole.
Theophylline anhydrous
The metabolism of Theophylline can be decreased when combined with Rabeprazole.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Rabeprazole.
Ticlopidine
The metabolism of Rabeprazole can be decreased when combined with Ticlopidine.
Tiludronate
The therapeutic efficacy of Tiludronic acid can be decreased when used in combination with Rabeprazole.
Tiludronic Acid
The therapeutic efficacy of Tiludronic acid can be decreased when used in combination with Rabeprazole.
Tipranavir
The serum concentration of Rabeprazole can be decreased when it is combined with Tipranavir.
Tocilizumab
The serum concentration of Rabeprazole can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Tolbutamide can be decreased when combined with Rabeprazole.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Rabeprazole.
Topiramate
The metabolism of Rabeprazole can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Rabeprazole.
Torsemide
The metabolism of Torasemide can be decreased when combined with Rabeprazole.
Tranylcypromine
The metabolism of Rabeprazole can be decreased when combined with Tranylcypromine.
Tretinoin
The metabolism of Tretinoin can be decreased when combined with Rabeprazole.
Trimethadione
The metabolism of Trimethadione can be decreased when combined with Rabeprazole.
Trimethoprim
The metabolism of Trimethoprim can be decreased when combined with Rabeprazole.
Troglitazone
The metabolism of Troglitazone can be decreased when combined with Rabeprazole.
Velpatasvir
The metabolism of Velpatasvir can be decreased when combined with Rabeprazole.
Vemurafenib
The serum concentration of Rabeprazole can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Rabeprazole can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Rabeprazole can be decreased when combined with Verapamil.
Voriconazole
The serum concentration of Rabeprazole can be increased when it is combined with Voriconazole.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Rabeprazole.
Voxilaprevir
The metabolism of Voxilaprevir can be decreased when combined with Rabeprazole.
Warfarin
The metabolism of Warfarin can be decreased when combined with Rabeprazole.
Zafirlukast
The metabolism of Zafirlukast can be decreased when combined with Rabeprazole.
Zidovudine
The metabolism of Zidovudine can be decreased when combined with Rabeprazole.
Ziprasidone
The metabolism of Rabeprazole can be decreased when combined with Ziprasidone.
Zoledronic Acid
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Rabeprazole.
Zoledronic Acid Anhydrous
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Rabeprazole.
Zopiclone
The metabolism of Zopiclone can be decreased when combined with Rabeprazole.
